Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : LH save search
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
Published: 2024-04-02 (Crawled : 12:30) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.1%
H: 0.01%
C: -1.94%
precision association cancer research meeting
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
Published: 2024-03-16 (Crawled : 16:20) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
precision cancer research impact diagnostics
Liquid Biopsy Market Set to Reach US$ 10.08 Billion by 2030 with Pioneering Breakthroughs in Cancer Detection and Management
Published: 2024-02-16 (Crawled : 19:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
management reach cancer set market
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
Published: 2023-11-16 (Crawled : 12:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.49%
H: 0.0%
C: -0.1%
cancer trial
Pancreatic Cancer Diagnostics Market: Growing Prevalence of Pancreatic Cancer Drives Demand for Innovative Diagnostic Tools
Published: 2023-10-27 (Crawled : 16:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: 0.0%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.5%
H: 0.69%
C: -2.89%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.22%
H: 0.23%
C: -1.69%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.57%
H: 0.6%
C: -2.01%
diagnostic cancer pancreatic tools growing diagnostics
United States Women Health Laboratory Testing Market Analysis 2023-2028 - Cancer Prevalence Among Women Creates New Opportunities
Published: 2023-08-08 (Crawled : 16:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.76%
H: 0.7%
C: 0.52%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 0.69%
H: 3.99%
C: 2.63%
health cancer women market
LABCORP EXPANDS ACCESS TO COLORECTAL CANCER SCREENING THROUGH PARTNERSHIP WITH THE CONFERENCE OF NATIONAL BLACK CHURCHES
Published: 2023-04-03 (Crawled : 12:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.26%
H: 0.76%
C: 0.2%
partnership conference cancer
Pancreatic Cancer Diagnostics Market is Likely to Upsurge at a CAGR of 7.5% by 2030, Size, Share, Trends, Demand, Growth, Opportunities and Competitors Analysis
Published: 2023-01-24 (Crawled : 21:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.58%
H: 0.85%
C: 0.47%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -0.89%
H: 0.75%
C: 0.12%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -1.09%
H: 1.65%
C: 1.14%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -1.0%
H: 0.1%
C: -1.2%
diagnostics cancer market pancreatic
Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials
Published: 2022-07-11 (Crawled : 22:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.44%
H: 0.69%
C: -0.1%
partnership trials cancer
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
Next-Generation Gynecological Cancer Diagnostics Market, 2031
Published: 2022-04-27 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.87%
H: 0.0%
C: 0.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.43%
H: 3.45%
C: 1.79%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -3.91%
H: 2.25%
C: 1.17%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -6.95%
H: 4.32%
C: -1.38%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -2.2%
H: 2.24%
C: -0.44%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: -6.64%
H: 1.78%
C: -1.42%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -2.62%
H: 3.04%
C: 0.09%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -3.78%
H: 2.05%
C: -1.05%
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: -3.5%
H: 3.75%
C: 0.29%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -2.84%
H: 1.46%
C: -1.17%
diagnostics cancer diagnostic
PetDx Raises $62 Million in Series B Financing to Scale Adoption of its Canine Multi-Cancer Early Detection Blood Test, OncoK9
Published: 2021-12-09 (Crawled : 14:00) - prnewswire.com
WOOF F | $1.655 0.3% 0.3% 2.4M
|
|
| O: 1.82%
H: 1.32%
C: -2.7%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -3.94%
H: 1.79%
C: -1.34%
blood test cancer
Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.82%
H: 0.83%
C: 0.0%
test genomic cancer bioscience collaboration
Labcorp and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care
Published: 2021-08-19 (Crawled : 23:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.48%
H: 1.53%
C: 1.26%
cancer research
Labcorp Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
Published: 2021-07-01 (Crawled : 00:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.36%
H: 0.61%
C: 0.42%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.0%
H: 1.38%
C: 1.3%
lung cancer therapy cancer approval diagnostic
Worldwide Solid Tumor Testing Industry to 2030 - Technological Advancements in the Field of Cancer Genomics Present Opportunities
Published: 2021-04-16 (Crawled : 17:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.77%
H: 0.33%
C: -0.02%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.61%
H: 0.74%
C: 0.73%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.47%
H: 0.94%
C: 0.6%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.0%
H: 0.08%
C: -3.64%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.01%
H: 0.51%
C: 0.22%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.36%
H: 0.17%
C: -0.03%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.61%
H: 0.74%
C: 0.73%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: -1.74%
H: 3.18%
C: 2.24%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.02%
H: 0.12%
C: -0.72%
test genomic cancer solid tumors
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.